KBI is a biopharma contract development & manufacturing organization driven to improve the quality of human life – we do this by serving our clients in the accelerated development of their needed medicines.
To date, we’ve served over 200 clients around the world.
We help our client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services in an agile, client-friendly partnering environment. Clients include global pharmaceutical and biotechnology companies and academic/non-profit organizations. Today we serve more than 200 clients in the US, Canada, Europe, Korea and Japan, including most of the top ten pharmaceutical companies. KBI was founded in 1996 and is based in Durham, North Carolina, near Research Triangle Park (RTP).
KBI’s extensive track record of successful process development and manufacturing programs is a result of our unique approach of applying the insight gained from our biophysical and biochemical protein characterization methodologies, towards the development of robust and scalable processes. KBI delivers expert and integrated process development and cGMP manufacturing of recombinant protein Active Pharmaceutical Ingredients (API) for our clients.
KBI’s scientific, quality and regulatory staff offers extensive experience – proven through numerous IND and NDA submissions – to meet the challenges that arise at all stages of drug development.